Comments
Medall Diagnostics, an integrated diagnostic services provider, today announced the receipt of approval from the Indian Council of Medical Research (ICMR) for conducting Covid-19 tests.
With a new 15,000 square feet central reference lab at Guindy in Chennai, equipped with state of the art equipment, Medall has the capacity to process close to 1,000 samples every day, positioning it as amongst the largest Covid-19 testing providers in the state.
Speaking on the approval received last evening, Arjun Ananth, CEO, Medall, said, “There is an urgent need to bring in more and more private laboratories for testing the samples. Reliable testing to screen for the disease is becoming increasingly apparent.”
He added: “As a quality-focused, integrated diagnostic service provider, Medall is uniquely placed to meet the growing demand for reliable and quick testing of Coronavirus samples using the standard Real-Time Polymerase Chain Reaction (RTPCR) testing methodology.”
He further added that he looks forward to working closely with the Tamil Nadu Government to enhance its testing capacity further.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.